Back to Search
RANDI AXELROD, MD
MD
Neonatal-Perinatal Medicine Physician
NPI: 1598711822Individual
Specialties, Licenses & Credentials
Pediatrics — Neonatal-Perinatal Medicine
Code: 2080N0001X
MA59228(NJ)
Research & Publications (14)
Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group.
PMID 19634157·Cancer·2009
3-trial
Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.
PMID 19043526·Transl Oncol·2008
8-other
A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study.
PMID 18296423·Ann Oncol·2008
3-trial
Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.
PMID 18281658·J Clin Oncol·2008
3-trial
Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer.
PMID 17765768·Otolaryngol Head Neck Surg·2007
8-other
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
PMID 17075122·J Clin Oncol·2006
3-trial
Evolution of contingent altruism when cooperation is expensive.
PMID 16427106·Theor Popul Biol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 446 BELLEVUE AVE
TRENTON, NJ 08618 - Phone
- (609) 393-2236
Quick Facts
- NPI
- 1598711822
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile